2019
1. M. A. H. Berrevoets, I. J. E. Kouijzer, K. Slieker, E. Aarntzen, B. J. Kullberg, J. T. Oever and C. P. Bleeker-Rovers "(18)F-FDG PET/CT-Guided Treatment Duration in Patients with High-Risk Staphylococcus Aureus Bacteremia: A Proof of Principle". J Nucl Med. 2019; 60; 998-1002; https://www.ncbi.nlm.nih.gov/pubmed/30552202
2. M. Bloemendal, W. W. van Willigen, K. F. Bol, M. J. Boers-Sonderen, J. J. Bonenkamp, J. E. M. Werner, E. Aarntzen, R. H. T. Koornstra, J. W. B. de Groot, I. J. M. de Vries, J. J. M. van der Hoeven, W. R. Gerritsen and J. H. W. de Wilt "Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy". Ann Surg Oncol. 2019; 26; 3945-3952; https://www.ncbi.nlm.nih.gov/pubmed/30830540
3. M. Boss, H. M. M. Rooijackers, M. Buitinga, M. J. R. Janssen, A. I. J. Arens, L. F. de Geus-Oei, L. P. Salm, B. E. de Galan and M. Gotthardt "PET imaging during hypoglycaemia to study adipose tissue metabolism". Eur J Clin Invest. 2019; 49; e13120; https://www.ncbi.nlm.nih.gov/pubmed/31002171
4. M. Coskunturk, E. Aarntzen and W. van der Velden "[Ring-shaped lesions on a lung scan]". Ned Tijdschr Geneeskd. 2019; 163; https://www.ncbi.nlm.nih.gov/pubmed/30719883
5. R. M. de Kruijff, R. Raave, A. Kip, J. Molkenboer-Kuenen, S. J. Roobol, J. Essers, S. Heskamp and A. G. Denkova "Elucidating the Influence of Tumor Presence on the Polymersome Circulation Time in Mice". Pharmaceutics. 2019; 11; https://www.ncbi.nlm.nih.gov/pubmed/31137479
6. M. M. Deken, D. L. Bos, W. Tummers, T. L. March, C. J. H. van de Velde, M. Rijpkema and A. L. Vahrmeijer "Multimodal image-guided surgery of HER2-positive breast cancer using [(111)In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model". EJNMMI Res. 2019; 9; 98; https://www.ncbi.nlm.nih.gov/pubmed/31754913
7. Y. H. W. Derks, D. Lowik, J. P. M. Sedelaar, M. Gotthardt, O. C. Boerman, M. Rijpkema, S. Lutje and S. Heskamp "PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery". Theranostics. 2019; 9; 6824-6839; https://www.ncbi.nlm.nih.gov/pubmed/31660071
8. F. M. K. Elekonawo, D. L. Bos, D. M. Goldenberg, O. C. Boerman and M. Rijpkema "Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models". EJNMMI Res. 2019; 9; 108; https://www.ncbi.nlm.nih.gov/pubmed/31828541
9. F. M. K. Elekonawo, S. Lutje, G. M. Franssen, D. L. Bos, D. M. Goldenberg, O. C. Boerman and M. Rijpkema "A pretargeted multimodal approach for image-guided resection in a xenograft model of colorectal cancer". EJNMMI Res. 2019; 9; 86; https://www.ncbi.nlm.nih.gov/pubmed/31485790
10. J. Garousi, F. J. Huizing, A. Vorobyeva, B. Mitran, K. G. Andersson, C. D. Leitao, F. Y. Frejd, J. Lofblom, J. Bussink, A. Orlova, S. Heskamp and V. Tolmachev "Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts". Sci Rep. 2019; 9; 14907; https://www.ncbi.nlm.nih.gov/pubmed/31624303
11. S. Heskamp, P. J. Wierstra, J. D. M. Molkenboer-Kuenen, G. W. Sandker, S. Thordardottir, J. Cany, D. Olive, J. Bussink, O. C. Boerman, H. Dolstra, E. Aarntzen and W. A. Hobo "PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer". Cancer Immunol Res. 2019; 7; 150-161; https://www.ncbi.nlm.nih.gov/pubmed/30459153
12. F. J. Huizing, J. Garousi, J. Lok, G. Franssen, B. A. W. Hoeben, F. Y. Frejd, O. C. Boerman, J. Bussink, V. Tolmachev and S. Heskamp "CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models". Sci Rep. 2019; 9; 18898; https://www.ncbi.nlm.nih.gov/pubmed/31827111
13. F. J. Huizing, B. A. W. Hoeben, G. M. Franssen, O. C. Boerman, S. Heskamp and J. Bussink "Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models". Mol Pharm. 2019; 16; 701-708; https://www.ncbi.nlm.nih.gov/pubmed/30550290
14. T. J. P. Jansen, S. A. M. van Lith, M. Boss, M. Brom, L. Joosten, M. Behe, M. Buitinga and M. Gotthardt "Exendin-4 analogs in insulinoma theranostics". J Labelled Comp Radiopharm. 2019; 62; 656-672; https://www.ncbi.nlm.nih.gov/pubmed/31070270
15. L. Joosten, M. Brom, H. Peeters, D. Bos, E. Himpe, L. Bouwens, O. Boerman and M. Gotthardt "Measuring the Pancreatic beta Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis". Mol Pharm. 2019; 16; 4024-4030; https://www.ncbi.nlm.nih.gov/pubmed/31345042
16. M. Krekorian, G. O. Fruhwirth, M. Srinivas, C. G. Figdor, S. Heskamp, T. H. Witney and E. Aarntzen "Imaging of T-cells and their responses during anti-cancer immunotherapy". Theranostics. 2019; 9; 7924-7947; https://www.ncbi.nlm.nih.gov/pubmed/31656546
17. R. M. Kruijff, R. Raave, A. Kip, J. Molkenboer-Kuenen, A. Morgenstern, F. Bruchertseifer, S. Heskamp and A. G. Denkova "The in vivo fate of (225)Ac daughter nuclides using polymersomes as a model carrier". Sci Rep. 2019; 9; 11671; https://www.ncbi.nlm.nih.gov/pubmed/31406320
18. D. Lobeek, F. C. M. Bouwman, E. Aarntzen, J. D. M. Molkenboer-Kuenen, U. E. Flucke, H. L. Nguyen, M. Vikkula, L. M. Boon, W. Klein, P. Laverman, W. J. G. Oyen, O. C. Boerman, S. Y. A. Terry, L. J. SchultzeKool and M. Rijpkema "A Clinical Feasibility Study To Image Angiogenesis in Patients With Arteriovenous Malformations Using (68)Ga-RGD PET/CT". J Nucl Med. 2019; https://www.ncbi.nlm.nih.gov/pubmed/31519800
19. S. Lutje, G. M. Franssen, K. Herrmann, O. C. Boerman, M. Rijpkema, M. Gotthardt and S. Heskamp "In Vitro and In Vivo Characterization of an (18)F-AlF-Labeled PSMA Ligand for Imaging of PSMA-Expressing Xenografts". J Nucl Med. 2019; 60; 1017-1022; https://www.ncbi.nlm.nih.gov/pubmed/30655329
20. S. Lutje, S. Heskamp, G. M. Franssen, C. Frielink, A. Kip, M. Hekman, G. Fracasso, M. Colombatti, K. Herrmann, O. C. Boerman, M. Gotthardt and M. Rijpkema "Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors". Theranostics. 2019; 9; 2924-2938; https://www.ncbi.nlm.nih.gov/pubmed/31244933
21. S. M. B. Peters, N. R. van der Werf, M. Segbers, F. H. P. van Velden, R. Wierts, K. Blokland, M. W. Konijnenberg, S. V. Lazarenko, E. P. Visser and M. Gotthardt "Towards standardization of absolute SPECT/CT quantification: a multi-center and multi-vendor phantom study". EJNMMI Phys. 2019; 6; 29; https://www.ncbi.nlm.nih.gov/pubmed/31879813
22. R. Raave, G. Sandker, P. Adumeau, C. B. Jacobsen, F. Mangin, M. Meyer, M. Moreau, C. Bernhard, L. Da Costa, A. Dubois, V. Goncalves, M. Gustafsson, M. Rijpkema, O. Boerman, J. C. Chambron, S. Heskamp and F. Denat "Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for (89)Zr-immunoPET". Eur J Nucl Med Mol Imaging. 2019; 46; 1966-1977; https://www.ncbi.nlm.nih.gov/pubmed/31161258
23. R. Raave, G. Sandker, P. Adumeau, C. B. Jacobsen, F. Mangin, M. Meyer, M. Moreau, C. Bernhard, L. Da Costa, A. Dubois, V. Goncalves, M. Gustafsson, M. Rijpkema, O. Boerman, J. C. Chambron, S. Heskamp and F. Denat "Additional information on "Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for (89)Zr-immunoPET"". Eur J Nucl Med Mol Imaging. 2019; https://www.ncbi.nlm.nih.gov/pubmed/31707427
24. M. Scholte, J. O. Barentsz, J. P. M. Sedelaar, M. Gotthardt, J. P. C. Grutters and M. M. Rovers "Modelling Study with an Interactive Model Assessing the Cost-effectiveness of (68)Ga Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Nano Magnetic Resonance Imaging for the Detection of Pelvic Lymph Node Metastases in Patients with Primary Prostate Cancer". Eur Urol Focus. 2019; https://www.ncbi.nlm.nih.gov/pubmed/30826284
25. E. M. M. Smeets, D. S. Withaar, W. Grootjans, J. J. Hermans, K. van Laarhoven, L. F. de Geus-Oei, M. Gotthardt and E. Aarntzen "Optimal respiratory-gated [(18)F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma". EJNMMI Res. 2019; 9; 24; https://www.ncbi.nlm.nih.gov/pubmed/30868318
26. J. Thomas, S. Ooms, M. Verbeek, J. Booij, M. Rijpkema, R. P. C. Kessels, S. Overeem and J. Claassen "Sleep-Cognition Hypothesis In maritime Pilots, what is the effect of long-term work-related poor sleep on cognition and amyloid accumulation in healthy middle-aged maritime pilots: methodology of a case-control study". BMJ Open. 2019; 9; e026992; https://www.ncbi.nlm.nih.gov/pubmed/31248923
27. C. van der Heijden, E. M. M. Smeets, E. Aarntzen, M. P. Noz, H. Monajemi, S. Kersten, C. Kaffa, A. Hoischen, J. Deinum, L. A. B. Joosten, M. G. Netea and N. P. Riksen "Arterial wall inflammation and increased hematopoietic activity in patients with primary aldosteronism". J Clin Endocrinol Metab. 2019; https://www.ncbi.nlm.nih.gov/pubmed/31875423
28. T. R. F. van Steenbergen, M. Smits, T. W. J. Scheenen, I. M. van Oort, J. Nagarajah, M. M. Rovers, N. Mehra and J. J. Futterer "(68)Ga-PSMA-PET/CT and Diffusion MRI Targeting for Cone-Beam CT-Guided Bone Biopsies of Castration-Resistant Prostate Cancer Patients". Cardiovasc Intervent Radiol. 2019; https://www.ncbi.nlm.nih.gov/pubmed/31444628
29. S. R. Verhoeff, S. C. van Es, E. Boon, E. van Helden, L. Angus, S. G. Elias, S. F. Oosting, E. H. Aarntzen, A. H. Brouwers, T. C. Kwee, S. Heskamp, O. S. Hoekstra, H. Verheul, A. A. M. van der Veldt, E. G. E. de Vries, O. C. Boerman, W. T. A. van der Graaf, W. J. G. Oyen and C. M. L. van Herpen "Lesion detection by [(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma". Eur J Nucl Med Mol Imaging. 2019; 46; 1931-1939; https://www.ncbi.nlm.nih.gov/pubmed/31172212
30. H. Westdorp, J. H. A. Creemers, I. M. van Oort, G. Schreibelt, M. A. J. Gorris, N. Mehra, M. Simons, A. L. de Goede, M. M. van Rossum, A. J. Croockewit, C. G. Figdor, J. A. Witjes, E. Aarntzen, R. D. M. Mus, M. Bruning, K. Petry, M. Gotthardt, J. O. Barentsz, I. J. M. de Vries and W. R. Gerritsen "Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer". J Immunother Cancer. 2019; 7; 302; https://www.ncbi.nlm.nih.gov/pubmed/31727154
31. P. Wierstra, G. Sandker, E. Aarntzen, M. Gotthardt, G. Adema, J. Bussink, R. Raave and S. Heskamp "Tracers for non-invasive radionuclide imaging of immune checkpoint expression in cancer". EJNMMI Radiopharm Chem. 2019; 4; 29; https://www.ncbi.nlm.nih.gov/pubmed/31696402